cladribine has been researched along with Hemorrhage in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blonski, JZ; Calbecka, M; Ceglarek, B; Chojnowski, K; Dmoszynska, A; Dwilewicz-Trojaczek, J; Gora-Tybor, J; Hellmann, A; Kloczko, J; Kostyra, A; Kowal, M; Kuliczkowski, K; Lewandowski, K; Mital, A; Nowak, W; Potoczek, S; Robak, T; Seferynska, I; Skotnicki, A; Stella-Holowiecka, B; Sulek, K; Trelinski, J; Warzocha, K; Wiater, E; Zawilska, K | 1 |
| Sallah, S; Wan, JY | 1 |
2 trial(s) available for cladribine and Hemorrhage
| Article | Year |
|---|---|
Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil--follow-up of PALG-CLL randomized trials.
Topics: Aged; Chlorambucil; Cladribine; Female; Follow-Up Studies; Hemorrhage; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prevalence; Retrospective Studies; Thrombocytopenia; Time Factors; Treatment Outcome | 2013 |
Efficacy of 2-chlorodeoxyadenosine in refractory factor VIII inhibitors in persons without hemophilia.
Topics: Aged; Autoantibodies; Autoimmune Diseases; Cladribine; Factor VIII; Female; Hemorrhage; Humans; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Salvage Therapy; Treatment Outcome | 2003 |